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Biological results and discussion
The cytotoxic potential of all newly synthesized bicyclic pyridones were evaluated in vitro against a panel of human tumor cell lines according to procedures described in the literature. 4 The tumor cell line panel consisted of myeloid leukaemia (HL-60 and K562), epidermoid carcinoma (A431), ovarian carcinoma (Skov-3), laryngeal carcinoma (Hep-2). Cisplatin (DDP) was used as the reference drug. The results of the cytotoxicity studies were summarized in Table 2~3 (IC 50 value, defined as the concentrations corresponding to 50% growth inhibition). As shown in Table 2~3 , the cytotoxic activities of 4a-g with trifluoromethyl substituent at position-7 of bicyclic pyridones is 4c>4g>4f>4d>4b>4a, the results showed that substitution of the position-8 with a electron-rich substituted group played a vital role in the modulation of the cytotoxic activities. Among them, compound 4c, bearing ethoxycarbonyl substituents, was the most active. The cytotoxicity to tumor cell lines of the methyl substituted 5,6-ring bicyclic pyridones 4h-l compliance with the laws as 4a~g. The 6,6-ring bicyclic pyridones 5a-e with trifluoromethyl substituent at position-8 of pyridones comply with the rule of compounds 4. It shown that 5d and 5e is more active to tumor cell lines. Hower, The methyl substituted 6,6-ring bicyclic pyridones 5f-i In contrast with the law as compounds 4 and 5a~e. Compared with all bicyclic pyridones derivatives 4~6, 6b~c has the more remarkable activity to the tumor cell line HepG2, A431 and A459. Compound 6c was found to be the most potent derivative with IC 50 values lower than 1.0μg/ml against 3 strains human tumor cell lines and more active than that of DDP.
So 6c can be considered promising leads for further structural modifications guided by the valuable information derivable from our detailed SARs. 
